Safety, Tolerability, Pharmacodynamic and Pharmacokinetic Effects of Single and Multiple-Doses of ATF936 and AXT914 Administered Orally in Healthy Subjects.
Clinical trial NCT00417261 · COMPLETED
Trial details
- NCT number
- NCT00417261
- Sponsor
- Novartis
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-11-01
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.